Back
Docebo, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
60
DCBO
Docebo, Inc.
Last Price:
$21.57
Seasonality Move:
-12.29%
Buy
57
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$105.07
Seasonality Move:
-6.7%
Buy
60
Docebo, Inc. (DCBO)
is a Buy
Is Docebo, Inc. a Buy, Sell or Hold?
-
The current Docebo, Inc. [DCBO] share price is $21.54. The Score for DCBO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
DCBO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $105.18. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DCBO Stock Price Chart
What is Docebo, Inc.'s stock price today?
-
The Docebo, Inc. share price today is $21.54Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DCBO is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $105.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
DCBO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.97 | Sell |
| Relative Strength Index (14 RSI): | 38.96 | Sell |
| Chaikin Money Flow: | -65089 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.7 - 23.76) | Sell |
| Bollinger Bands (100): | (24.01 - 31.21) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 51.73 | Buy |
| Chaikin Money Flow: | -33785 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.75 - 107.07) | Buy |
| Bollinger Bands (100): | (93.01 - 107.07) | Buy |
DCBO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.3 | Buy |
| 20-day SMA: | 21.63 | Sell |
| 50-day SMA: | 24.61 | Sell |
| 200-day SMA: | 28.46 | Sell |
| 8-day EMA: | 21.46 | Buy |
| 20-day EMA: | 22.05 | Sell |
| 50-day EMA: | 24.18 | Sell |
| 200-day EMA: | 29.51 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.38 | Sell |
| 20-day SMA: | 102.79 | Buy |
| 50-day SMA: | 104.38 | Buy |
| 200-day SMA: | 80.61 | Buy |
| 8-day EMA: | 104.86 | Buy |
| 20-day EMA: | 104.36 | Buy |
| 50-day EMA: | 102.98 | Buy |
| 200-day EMA: | 85.73 | Buy |
Docebo, Inc. Earnings Growth & DCBO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.21 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.66 per share.
Docebo, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||